Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-12-20
2010-10-26
Dentz, Bernard (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07820834
ABSTRACT:
Compounds useful as immunosuppressive, anti-inflammatory and anticancer agents and methods of their preparation and use are described. The compounds are analogs or derivatives of triptolide and related compounds, modified at the 5- and/or 6-position relative to the naturally occurring compounds.
REFERENCES:
patent: 4005108 (1977-01-01), Kupchan et al.
patent: 5192817 (1993-03-01), Takaishi et al.
patent: 5294443 (1994-03-01), Lipsky et al.
patent: 5430054 (1995-07-01), Qian et al.
patent: 5468772 (1995-11-01), Xu et al.
patent: 5580562 (1996-12-01), Lipsky et al.
patent: 5648376 (1997-07-01), Strobel et al.
patent: 5663335 (1997-09-01), Qi et al.
patent: 5759550 (1998-06-01), Weidmann et al.
patent: 5843452 (1998-12-01), Weidmann et al.
patent: 5919816 (1999-07-01), Hausheer et al.
patent: 5962516 (1999-10-01), Qi et al.
patent: 5972998 (1999-10-01), Jung et al.
patent: 6004999 (1999-12-01), Jung et al.
patent: 6011042 (2000-01-01), Greenwald et al.
patent: 6103875 (2000-08-01), Martinez-Miller et al.
patent: 6150539 (2000-11-01), Musser
patent: 6294546 (2001-09-01), Rosen et al.
patent: 6329148 (2001-12-01), Rosen et al.
patent: 6458537 (2002-10-01), Staub et al.
patent: 6537984 (2003-03-01), Rosen et al.
patent: 6548537 (2003-04-01), Dai et al.
patent: 6569893 (2003-05-01), Dai et al.
patent: 6599499 (2003-07-01), Rosen et al.
patent: 6620843 (2003-09-01), Fidler et al.
patent: 6777441 (2004-08-01), Wang et al.
patent: 6943259 (2005-09-01), Dai et al.
patent: 7019151 (2006-03-01), Dai et al.
patent: 7098348 (2006-08-01), Dai et al.
patent: 7417069 (2008-08-01), Dai et al.
patent: 7626044 (2009-12-01), Li et al.
patent: 2002/0077350 (2002-06-01), Babish et al.
patent: 2002/0099051 (2002-07-01), Fidler et al.
patent: 2004/0018260 (2004-01-01), Ren et al.
patent: 2004/0152767 (2004-08-01), Dai et al.
patent: 2004/0198808 (2004-10-01), Dai et al.
patent: 2004/0235943 (2004-11-01), Dai et al.
patent: 2005/0288645 (2005-12-01), LaVon
patent: 2007/0244080 (2007-10-01), Fidler et al.
patent: 2007/0249048 (2007-10-01), Dai et al.
patent: 2007/0282114 (2007-12-01), An et al.
patent: 2008/0287530 (2008-11-01), Yuan et al.
patent: 1052859 (1991-07-01), None
patent: 1317248 (2001-10-01), None
patent: 0 156 643 (1985-10-01), None
patent: 03 178977 (1991-08-01), None
patent: WO 94/26265 (1994-11-01), None
patent: WO 98/52933 (1998-11-01), None
patent: WO 98/52951 (1998-11-01), None
patent: WO 00/12483 (2000-03-01), None
patent: WO 00/63212 (2000-10-01), None
patent: WO 02/070472 (2002-09-01), None
patent: WO 02/074759 (2002-09-01), None
patent: WO 03/101951 (2003-12-01), None
patent: WO2004/058770 (2004-07-01), None
patent: WO2005/000291 (2005-01-01), None
patent: WO2005/020887 (2005-03-01), None
patent: WO 2005/062913 (2005-07-01), None
patent: WO 2005/084365 (2005-09-01), None
patent: WO 2006/012204 (2006-02-01), None
Anderson, Wayne K. et al., “Synthesis, Evaluation of Chemical Reactivity, and Murine Antineoplastic Activity of 2-Hydroxy-5-(3,4-dichlorophenyl)-6,7-bis(hydroxymethyl)-2,3-dihydro-1H-pyrrolizine Bis(2-propylcarbamate) and 2-Acyloxy Derivatives as Potential Water-Soluble Prodrugs1”,J. Med. Chem., 26:1333-1338 (1983).
Aumuller, G. et al., “Intermediate filaments in sertoli cells”,Microscopy Research and Technique, 20:50-72(1992).
Becker, K. et al., “Thioredoxin reductase as a pathophysiological factor and drug target”,Eur. J. Biochem., 267(20):6118-6125 (2000).
Berg, D. et al., “14-3-3 Proteins in the nervous system”,Nature Reviews Neuroscience,. 4:752-62 (2003).
Britton, R. et al., “New okadaic acid analogues from the marine spongeMerriamum oxeatoand their effect on mitosis”,J. Nat. Prod., 66:838-43 (2003).
Chang, W-T. et al., “Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway”,The Journal of Biological Chemistry, 276(3):2221-2227 (2001).
Chen et al., “Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model”,Transplantation, 73(1):115 (2002).
Chen et al., “Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion”,Transplantation, 70(10):1442-1447 (2000).
Cheng et al., “Research on extraction technology of Tripterygium”,Chinese Journal of Pharmaceuticals, 21(10):435-436 (No English translation) (1990).
Cheng, X.X. et al., Yao Xue Xue Bao,ACTA Pharmaceutica Sinica, 37:339-342 (2002) (English Abstract translation).
Dan et al. , “Studies on triepoxide analogs of triptolide”,Tetrahedron Letters, 38(39):6865-6868 (1997).
De Groot Franciscus M. H. et al., “Synthesis and Biological Evaluation of 2′-Carbamate-Linked and 2′-Carbonate-Linked Prodrugs of Paclitaxel: Selective Activation by the Tumor-Associated Protease Plasmin”,J. Med. Chem., 43:3093-3102 (2000).
De Quan Yu et al., “Chemical Transformation of Triptolide”,Chinese Chemical Letters, 2(12):937-940 (1991).
Dittert, L.W. et al., “Acetaminophen Prodrugs I Synthesis, Physicochemical Properties, and Analgesic Activity”,Journal of Pharmaceutical Sciences, 57(5):774-780 (1968).
Dittert, L.W. et al., “Acetaminophen Prodrugs II Effect of Structure and Enzyme Source on Enzymatic and Nonenzymatic Hydrolysis of Carbonate Esters”,Journal of Pharmaceutical Sciences, 57(5):780-783 (1968).
Fidler, J.M. et al., “PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy”,Molecular Cancer Therapeutics, 2(9):855-62 (2003).
Fidler, J.M. et al., “Immunosuppressive activity of the Chinese medicinal plantTripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract”,Transplantation, 74(4):445-457 (2002).
Fruman, D.A. et al., “Phosphoinositide Kinases”,Ann. Rev. Biochem., 67:481-507 (1998).
Fu et al., “14-3-3 Proteins: Structure, Function, and regulation”,Ann. Rev. Pharmacol. Toxicol., 40:617-47 (2000).
Gabbiani, G., “The myofibroblast in wound healing and fibrocontractive diseases”,Journal of Pathology, 200:500-503 (2003).
Garcia, A. et al., “Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis”,Biochimie, 85:721-726 (2003).
Gilles, C. et al., “Transactivation of vimentin by beta-catenin in human breast cancer cells”,Cancer Research, 63(10):2658-2664 (2003).
Gleichmann, E. et al., “Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases”,Immunology Today, 5(11):324-332 (1984).
Goto, Y. et al., “Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation”,Cell Tissue Res., 315:209-221 (2004).
Gross, T.J. and Hunninghake, G.W., “Idiopathic pulmonary fibrosis”,N. Engl. J. Med., 345(7):517-525 (2001).
Hansen, Kristian T. et al., “Carbamate Ester Prodrus of Dopaminergic Compounds: Synthesis, Stability, and Bioconversion”,Journal of Pharmaceutical Sciences, 80(8):793-798 (1991).
Hansen, Laila B. et al., “Ketobemidone prodrugs for buccal delivery”,Acta Pharm. Nord., 3(2):77-82 (1991).
He, Q. et al., “Neuroprotective eggects ofTripterygium wilfordii Hook FMonomer T10on glutamate induced PC12 cell line damage and its mechanism”,Beijing Da Xue Xue Bao, Journal of Peking University(Health Sciences), 35(3):252-5 (Jun. 2003) (English Abstract Translation).
Houtman, J.C. et al., “Early phosphorylation kinetics of proteins involved in proximal TCR-mediated signaling pathways”,Journal of Immunology, 175(4):2449-2458 (2005).
Huang, Tien L. et al., “Hydrolysis of Carbonates, Thiocarbonates, Carbamates, and Carboxylic Esters of α-Naphthol, β-Naphthol, and ρ-Nitroph
Dai Dongcheng
Musser John H.
Yuan Hongwei
Dehlinger Peter J.
Dentz Bernard
King & Spalding LLP
Myers Fitch Susan J.
Pharmagenesis, Inc.
LandOfFree
Triptolide 5,6-derivatives as immunomodulators and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triptolide 5,6-derivatives as immunomodulators and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triptolide 5,6-derivatives as immunomodulators and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186480